Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Saved in:
| Title: | Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms. |
|---|---|
| Authors: | Kruse CA; Department of Immunology, University of Colorado Health Sciences Center, Denver 80262, USA., Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2000 Jan; Vol. 7 (1), pp. 118-27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 10678364 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kruse+CA%22">Kruse CA</searchLink>; Department of Immunology, University of Colorado Health Sciences Center, Denver 80262, USA.<br /><searchLink fieldCode="AU" term="%22Lamb+C%22">Lamb C</searchLink><br /><searchLink fieldCode="AU" term="%22Hogan+S%22">Hogan S</searchLink><br /><searchLink fieldCode="AU" term="%22Smiley+WR%22">Smiley WR</searchLink><br /><searchLink fieldCode="AU" term="%22Kleinschmidt-Demasters+BK%22">Kleinschmidt-Demasters BK</searchLink><br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2000 Jan; Vol. 7 (1), pp. 118-27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0929-1903 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10678364 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/sj.cgt.7700097 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 118 Titles: – TitleFull: Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kruse CA – PersonEntity: Name: NameFull: Lamb C – PersonEntity: Name: NameFull: Hogan S – PersonEntity: Name: NameFull: Smiley WR – PersonEntity: Name: NameFull: Kleinschmidt-Demasters BK – PersonEntity: Name: NameFull: Burrows FJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2000 Jan Type: published Y: 2000 Identifiers: – Type: issn-print Value: 0929-1903 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Cancer gene therapy Type: main |
| ResultId | 1 |
